Literature DB >> 2033475

Dietary plant materials and development of diabetes in the BB rat.

J Hoorfar1, F W Scott, H E Cloutier.   

Abstract

The present study was designed to examine further the impact of individual plant protein sources found in a diabetogenic, cereal-based, rodent laboratory diet, NIH-07 [open formula, nonpurified rat and mouse diet (positive control)], on the development of diabetes. Diabetes-prone BB rats that were pan-T(OX19+)-lymphopenic were fed a low diabetogenic diet during gestation and lactation. Progeny of these rats were fed a normal or autoclaved NIH-07 diet, or one of eight other diets based on the AIN-76A formulation, with modified protein sources as follows: hydrolyzed casein (HC), soybean meal, HC+ trypsin inhibitor (TI) in water (2 mg/mL, wheat germ, alfalfa seeds, Brewer's yeast, red lentils and a plant protein mixture. Feeding soybean meal increased the incidence of diabetes compared with the negative control, HC diet (47% vs. 12% incidence, P = 0.02). Wheat germ, alfalfa seeds and plant protein mixture resulted in an intermediate incidence of diabetes of 33%; the incidence was lower for Brewer's yeast and lentils (20% and 13%). Autoclaving (121 degrees C, 10 min) the NIH-07 diet or the presence of TI in drinking water had a minimal effect on diabetes frequency, suggesting heat-labile plant toxicants were not directly involved. Thus, certain dietary plant protein sources or associated agents may influence the development of spontaneous diabetes in the BB rat.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033475     DOI: 10.1093/jn/121.6.908

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  12 in total

Review 1.  Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes.

Authors:  Mikael Knip
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Low incidence of autoimmune type I diabetes in BB rats fed a hydrolysed casein-based diet associated with early inhibition of non-macrophage-dependent hyperexpression of MHC class I molecules on beta cells.

Authors:  X B Li; F W Scott; Y H Park; J W Yoon
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

3.  A diet enriched in protein accelerates diabetes manifestation in NOD mice.

Authors:  K Schneider; H Laube; T Linn
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

4.  A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus.

Authors:  J Norris; M Pietropaolo
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

5.  Dietary gluten alters the balance of pro-inflammatory and anti-inflammatory cytokines in T cells of BALB/c mice.

Authors:  Julie C Antvorskov; Petra Fundova; Karsten Buschard; David P Funda
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

6.  Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR).

Authors: 
Journal:  Pediatr Diabetes       Date:  2007-06       Impact factor: 4.866

7.  Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.

Authors:  Julie Christine Antvorskov; Petra Fundova; Karsten Buschard; David P Funda
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

8.  A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice.

Authors:  E H Adlercreutz; C Weile; J Larsen; K Engkilde; D Agardh; K Buschard; J C Antvorskov
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

9.  Prevention or early cure of type 1 diabetes by intranasal administration of gliadin in NOD mice.

Authors:  David P Funda; Petra Fundova; Axel Kornerup Hansen; Karsten Buschard
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

Review 10.  Dietary gluten and the development of type 1 diabetes.

Authors:  Julie C Antvorskov; Knud Josefsen; Kåre Engkilde; David P Funda; Karsten Buschard
Journal:  Diabetologia       Date:  2014-05-29       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.